Advances in the treatment of gastric cancer: 2020–2021
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Gastroenterology
Reference8 articles.
1. A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial;Park;Ann Oncol,2021
2. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer;Kelly;N Engl J Med,2021
3. Randomized phase III KEYNOTE-181 study of pembrolizumab versus chemotherapy in advanced esophageal cancer;Kojima;J Clin Oncol,2020
4. Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: the KEYNOTE-062 phase 3 randomized clinical trial;Shitara;JAMA Oncol,2020
5. LBA6_PR nivolumab (nivo) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC)/esophageal adenocarcinoma (EAC): first results of the CheckMate 649 study;Moehler;Ann Oncol,2020
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Application of Deep Learning Model and Machine Learning Detection Algorithm for Gastric Cancer Patients Undergoing Chemotherapy;Journal of Biomedical Nanotechnology;2024-09-01
2. Identifcation and Validation of EMT-immune-related Prognostic Biomarkers CMTM3 and LTBP2 in Gastric Cancer;2024-07-31
3. The prognostic, diagnostic, and therapeutic impact of Long noncoding RNAs in gastric cancer;Cancer Genetics;2024-04
4. Diagnostic value of dual-source, dual-energy computed tomography combined with the neutrophil-lymphocyte ratio for discriminating gastric signet ring cell from mixed signet ring cell and non-signet ring cell carcinomas;Abdominal Radiology;2024-03-25
5. Complementary biomarkers of computed tomography for diagnostic grading of gastric cancer: DSCC1 and GINS1;Aging;2024-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3